Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $76.6700 (5.62%) ($76.6700 - $76.6700) on Wed. Jan. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.97% (three month average) | RSI | 94 | Latest Price | $76.6700(5.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.6% a day on average for past five trading days. | Weekly Trend | LGND advances 4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(49%) IWM(48%) IWC(47%) IWN(47%) IWO(46%) | Factors Impacting LGND price | LGND will decline at least -1.985% in a week (0% probabilities). VIXM(-24%) SHY(-18%) IGOV(-10%) GLD(-7%) BND(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.985% (StdDev 3.97%) | Hourly BBV | 2.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $72.28(6.07%) | 10 Day Moving Average | $71.51(7.22%) | 20 Day Moving Average | $69.15(10.87%) | To recent high | -12.9% | To recent low | 24% | Market Cap | $1.232b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |